• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜静脉阻塞的危险因素综述。

A review of risk factors for retinal vein occlusions.

机构信息

Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.

Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Aalborg, Denmark.

出版信息

Expert Rev Cardiovasc Ther. 2022 Sep;20(9):761-772. doi: 10.1080/14779072.2022.2112667. Epub 2022 Aug 19.

DOI:10.1080/14779072.2022.2112667
PMID:35972726
Abstract

INTRODUCTION

Risk factors for retinal vein occlusion have been extensively studied, with varying population sizes. Smaller populations result in less certain measures of associations. The present review included studies with a relevant population size to identify clinically relevant risk factors for retinal vein occlusion. Understanding the risk factors of retinal vein occlusion is important for the management of these patients.

AREAS COVERED

A comprehensive literature review was conducted through a systematic literature search in PubMed and Embase. Additional studies were selected from cross references in the assessed studies. Weighted effect measures were calculated for all included risk factors.Risk factors associated with retinal vein occlusion included cardiovascular diseases, eye diseases, systemic diseases, medical interventions, and sociodemographic factors.

EXPERT OPINION

This review provided an extensive overview of a wide variety of risk factors increasing the risk of developing retinal vein occlusion. The severity of the identified risk factors indicated that these patients have been in contact with the health care system before their retinal vein occlusion event. Therefore, the clinical course for patients with retinal vein occlusion may benefit from a multidisciplinary collaboration between ophthalmologists and especially cardiologists.

摘要

简介

已经对视网膜静脉阻塞的危险因素进行了广泛研究,研究人群的规模大小不一。较小的人群会导致关联的衡量标准不太确定。本综述纳入了具有相关人群规模的研究,以确定视网膜静脉阻塞的临床相关危险因素。了解视网膜静脉阻塞的危险因素对于这些患者的治疗非常重要。

涵盖领域

通过在 PubMed 和 Embase 中进行系统的文献检索,进行了全面的文献综述。还从评估研究的参考文献中选择了其他研究。对所有纳入的危险因素均计算了加权效应量。与视网膜静脉阻塞相关的危险因素包括心血管疾病、眼部疾病、系统性疾病、医疗干预和社会人口因素。

专家意见

本综述广泛概述了多种增加视网膜静脉阻塞风险的危险因素。所确定的危险因素的严重程度表明,这些患者在视网膜静脉阻塞事件之前已经接触过医疗保健系统。因此,视网膜静脉阻塞患者的临床病程可能受益于眼科医生和心脏病专家之间的多学科合作。

相似文献

1
A review of risk factors for retinal vein occlusions.视网膜静脉阻塞的危险因素综述。
Expert Rev Cardiovasc Ther. 2022 Sep;20(9):761-772. doi: 10.1080/14779072.2022.2112667. Epub 2022 Aug 19.
2
Risk factors for retinal vein occlusions. A case-control study.视网膜静脉阻塞的危险因素。一项病例对照研究。
Ophthalmology. 1992 Apr;99(4):509-14. doi: 10.1016/s0161-6420(92)31940-2.
3
Systemic disorders associated with retinal vascular occlusion.与视网膜血管阻塞相关的全身性疾病。
Curr Opin Ophthalmol. 2000 Dec;11(6):462-7. doi: 10.1097/00055735-200012000-00013.
4
The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.视网膜静脉阻塞的流行病学:比弗迪尔姆眼科研究
Trans Am Ophthalmol Soc. 2000;98:133-41; discussion 141-3.
5
Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies.视网膜静脉阻塞和小动脉栓塞的心血管危险因素:社区动脉粥样硬化风险研究及心血管健康研究
Ophthalmology. 2005 Apr;112(4):540-7. doi: 10.1016/j.ophtha.2004.10.039.
6
[Risk factors in central retinal vein occlusion].[视网膜中央静脉阻塞的危险因素]
Oftalmologia. 2011;55(2):27-37.
7
Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review.视网膜动脉阻塞和视网膜静脉阻塞与死亡率、中风及心肌梗死的关联:一项系统综述
Eye (Lond). 2016 Aug;30(8):1031-8. doi: 10.1038/eye.2016.111. Epub 2016 Jun 3.
8
[Extra-ocular etiologic factors in retinal vein occlusion. Retrospective study of 24 patients].[视网膜静脉阻塞的眼外病因因素。对24例患者的回顾性研究]
Rev Med Interne. 2000 Mar;21(3):231-5. doi: 10.1016/s0248-8663(00)80041-7.
9
Systematic study of retinal vein occlusion in young patients. Case report and review of the literature.年轻患者视网膜静脉阻塞的系统研究。病例报告及文献综述。
Arch Soc Esp Oftalmol. 2016 Mar;91(3):130-3. doi: 10.1016/j.oftal.2015.10.015. Epub 2015 Dec 23.
10
10-Year Framingham risk in patients with retinal vein occlusion: a systematic review and meta-analysis.视网膜静脉阻塞患者的 10 年Framingham 风险:系统评价和荟萃分析。
Can J Ophthalmol. 2013 Feb;48(1):40-45.e1. doi: 10.1016/j.jcjo.2012.08.017.

引用本文的文献

1
Exploring the role of oxidative stress in retinal vein occlusion: an updated and comprehensive review on the pathophysiology and treatment perspectives.探索氧化应激在视网膜静脉阻塞中的作用:关于病理生理学和治疗前景的最新综合综述
Int Ophthalmol. 2025 Aug 28;45(1):358. doi: 10.1007/s10792-025-03687-z.
2
Retinal Vascular Occlusion Following COVID-19 Vaccination: A Comprehensive Review of Observational Study and Pathophysiological Mechanisms.COVID-19疫苗接种后的视网膜血管阻塞:观察性研究与病理生理机制的综合综述
Vaccines (Basel). 2025 Jul 7;13(7):733. doi: 10.3390/vaccines13070733.
3
The effect of coagulation traits on the risk of retinal vein occlusion: a mendelian randomization study.
凝血特征对视网膜静脉阻塞风险的影响:一项孟德尔随机化研究。
Sci Rep. 2025 Jan 24;15(1):3052. doi: 10.1038/s41598-025-87648-7.
4
Mendelian randomization indicates a causal contribution of type 2 diabetes to retinal vein occlusion.孟德尔随机化表明 2 型糖尿病对视网膜静脉阻塞有因果贡献。
Front Endocrinol (Lausanne). 2023 May 8;14:1146185. doi: 10.3389/fendo.2023.1146185. eCollection 2023.
5
Research progress on diagnosing retinal vascular diseases based on artificial intelligence and fundus images.基于人工智能和眼底图像诊断视网膜血管疾病的研究进展
Front Cell Dev Biol. 2023 Mar 28;11:1168327. doi: 10.3389/fcell.2023.1168327. eCollection 2023.
6
Intravitreal Fluocinolone Acetonide Implant (ILUVIEN) for the Treatment of Retinal Conditions. A Review of Clinical Studies.玻璃体腔内氟轻松醋酸酯植入物(ILUVIEN)治疗视网膜疾病。临床研究综述。
Drug Des Devel Ther. 2023 Mar 30;17:961-975. doi: 10.2147/DDDT.S403259. eCollection 2023.
7
Alterations in Retinal Vessel Diameters in Patients with Retinal Vein Occlusion before and after Treatment with Intravitreal Ranibizumab.玻璃体内注射雷珠单抗治疗前后视网膜静脉阻塞患者视网膜血管直径的变化
J Pers Med. 2023 Feb 17;13(2):351. doi: 10.3390/jpm13020351.